Urol. praxi. 2024;25(3):136-138 | DOI: 10.36290/uro.2024.057

Oncourological aspects of medical care of transgender population

doc. MUDr. Radka Lohynská, Ph.D.1, MUDr. Zdeňka Pechačová2, MUDr. Michaela Matoušková1, 3, MUDr. Marcela Fontana, Ph.D.3, 4
1 Onkologická klinika 1. LF UK a FTN, Praha
2 Ústav radiační onkologie 1. LF UK a FN Bulovka, Praha
3 Urocentrum, Praha
4 Urologická klinika 2. LF UK a FN Motol, Praha

In oncourological care, it is crucial to address not only aspects affecting diagnosis and treatment but also to focus on oncological screening in the transgender population. The occurrence of cancerous diseases presents a different spectrum and frequency of tumors. Oncological treatment depends not only on the type and advancement of the tumor but also on respecting the patient's wishes.

Keywords: transgender individuals, urology, cancer screening, oncology.

Accepted: October 1, 2024; Published: November 14, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lohynská R, Pechačová Z, Matoušková M, Fontana M. Oncourological aspects of medical care of transgender population. Urol. praxi. 2024;25(3):136-138. doi: 10.36290/uro.2024.057.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 14.11.2025

    References

    1. Berner A, Saunders D. ESMO E-Learning: Oncological Considerations for the LGBTQ Patient. European Society for Medical Oncology (ESMO), kurz dostupný on-line na https://oncologypro.esmo.org.
    2. Safer JD, Tangpricha V. Care of Transgender Persons. N Engl J Med. 2019;381(25):2451-2460. Go to original source... Go to PubMed...
    3. Smart AC, Liu KX, Domogauer JD, et al. Gender-Affirming Surgery and Cancer: Considerations for Radiation Oncologists for Pelvic Radiation in Transfeminine Patients. Int J Radiat Oncol Biol Phys. 2023;117(2):301-311. Go to original source... Go to PubMed...
    4. Ceres M, Quinn GP, Loscalzo M, et al. Cancer Screening Considerations and Cancer Screening Uptake for Lesbian, Gay, Bisexual, and Transgender Persons. Semin Oncol Nurs. 2018;34(1):37-51. Go to original source... Go to PubMed...
    5. Turčan P. Specifika urologické a andrologické léčby LGBT komunity. Urol. Praxi. 2019;20(1):32-35. Go to original source...
    6. Gooren L, Morgentaler A. Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens. Andrologia. 2014;46(10):1156-1160. Go to original source... Go to PubMed...
    7. Manfredi C, Ditonno F, Franco A et al. Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges. Curr Oncol Rep. 2023;25(12):1431-1443. Go to original source... Go to PubMed...
    8. Pechačová Z, Lohynská R, Drbohlavová T. Specifika onkologické péče u LGBTQI+ pacientů. Onkologie 2022;16(4):189-194. Go to original source...
    9. Ingham MD, Lee RJ, MacDermed D et al. Prostate cancer in transgender women. Urol Oncol. 2018;36(12):518-525. Go to original source... Go to PubMed...
    10. Sterling J, Garcia MM. Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Transl Androl Urol. 2020;9(6):2771-2785. Go to original source... Go to PubMed...
    11. Weyers S, Garland SM, Cruickshank M, et al. Cervical cancer prevention in transgender men: a review. BJOG. 2021;128(5):822-826. Go to original source... Go to PubMed...
    12. Connolly D, Hughes X, Berner A. Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: A systematic narrative review. Prev Med. 2020;135:106071. Go to original source... Go to PubMed...
    13. Pothuri VS, Anzelmo M, Gallaher E, et al. Transgender Males on Gender-Affirming Hormone Therapy and Hepatobiliary Neoplasms: A Systematic Review. Endocr Pract. 2023;29(10):822-829. Go to original source... Go to PubMed...
    14. D'hoore L, T'Sjoen G. Gender-affirming hormone therapy: An updated literature review with an eye on the future. J Intern Med. 2022;291(5):574-592. Go to original source... Go to PubMed...
    15. Clarke CN, Cortina CS, Fayanju OM, et al. Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care. Ann Surg Oncol. 2022;29(4):2176-2180. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.